Compelo Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More

RegenLab to distribute Stryker RegenKit-THT

RegenLab has entered into an agreement with Stryker Joint Preservation, a unit of Stryker Orthopaedics, to distribute Stryker's RegenKit-THT, a one-step system designed for the preparation of autologous platelet-rich plasma (A-PRP) from a small sample of blood.

Stryker claims, in comparison to competitive offerings, the A-PRP prepared using RegenKit-THT provides the highest platelet recovery and viability.

It helps maximize efficiency in the office and OR with a minimal eight minute centrifuge spin time and reduced number of steps.

Stryker Joint Preservation vice president and general manager Matt Moreau said the addition of the RegenKit for PRP therapy to Stryker’s Joint Preservation Biologics portfolio allows them to provide surgeons with this emerging therapy for orthopaedic applications.